Chasing My Cure in the news!

Reflecting on 10 Years in Overtime – Time I Never Thought I’d Have At Every Cure, we are utilizing artificial intelligence to identify the most promising new uses for existing drugs across all 3,000 drugs and 20,000 diseases and we need your help to make the biggest impact possible! Whether it’s forwarding this email to a friend or…

Wow, my head is spinning from these recent clinical trial results. Within minutes of one another, two conflicting studies were released. The first I’ll highlight is of tocilizumab (the drug that my friend and colleague Kazu Yoshizaki developed to treat Castleman disease and tested on himself to prove that it was safe before giving it…

I am beyond honored to be named the 2023 Philadelphia Citizen of the Year by The Philadelphia Citizen. This recognition is a testament to our amazing team’s work and the support that so many of you have shared with us! It has been the honor of a lifetime to work with our amazing teams at…

This weekend, I was going to go to San Diego to see my best friends from medical school for the first time in 2-3 years and then to SF for 4 talks that I was really excited about! I was going to evangelize about repurposing drugs for new uses to save lives (I’m literally alive…

Congress should encourage companies to repurpose existing drugs for rare diseases, potentially doubling the number of treatment options for patients. Lately, there has been a national uproar over the rising cost of medicine in the U.S. While this is an important public debate, it largely overlooks the critical importance of innovation, which is desperately needed…

You’ve probably seen the term “cytokine storm” in the news a lot recently. That’s because COVID19 is able to unleash a cytokine storm in the most sick cases. As someone who has survived 5 deadly COVID19-like cytokine storms due to idiopathic multicentric Castleman disease and who studies cytokine storms in my lab, I thought I’d…